These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28541790)

  • 21. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm.
    Saleem AM; Paulus JK; Shapter AP; Baxter NN; Roberts PL; Ricciardi R
    Obstet Gynecol; 2011 Mar; 117(3):643-649. PubMed ID: 21343768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies.
    Fang JH; Yu XM; Zhang SH; Yang Y
    J Cancer Res Ther; 2018; 14(Supplement):S184-S189. PubMed ID: 29578171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
    Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
    Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
    Castle PE; Solomon D; Schiffman M; Wheeler CM
    J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anal and Cervical High-Risk Human Papillomavirus Genotyping in Women With and Without Genital Neoplasia.
    Bregar AJ; Cronin B; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M; Robison K
    J Low Genit Tract Dis; 2018 Apr; 22(2):115-119. PubMed ID: 29481422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
    Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
    J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.
    Jensen KE; Thomsen LT; Schmiedel S; Frederiksen K; Norrild B; van den Brule A; Iftner T; Kjær SK
    Sex Transm Infect; 2014 Nov; 90(7):550-5. PubMed ID: 24728044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytology-based screening for anal intraepithelial neoplasia in women with a history of cervical intraepithelial neoplasia or cancer.
    Wohlmuth C; Ghorab Z; Shier M; Tinmouth J; Salit IE; Covens A; Zhang L; Vicus D
    Cancer Cytopathol; 2021 Feb; 129(2):140-147. PubMed ID: 33002327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
    Hessol NA; Holly EA; Efird JT; Minkoff H; Schowalter K; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
    AIDS; 2009 Jan; 23(1):59-70. PubMed ID: 19050387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of human papillomavirus infection and related diseases in Israel.
    Shavit O; Roura E; Barchana M; Diaz M; Bornstein J
    Vaccine; 2013 Nov; 31 Suppl 8():I32-41. PubMed ID: 24229717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3.
    Giannella L; Giorgi Rossi P; Delli Carpini G; Di Giuseppe J; Bogani G; Gardella B; Monti E; Liverani CA; Ghelardi A; Insinga S; Raspagliesi F; Spinillo A; Vercellini P; Roncella E; Ciavattini A
    Gynecol Oncol; 2021 Jun; 161(3):741-747. PubMed ID: 33795132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Lindquist S; Frederiksen K; Petersen LK; Kjær SK
    Int J Cancer; 2024 Jul; 155(1):61-70. PubMed ID: 38418719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anal Cytology and Human Papillomavirus Genotyping in Women With a History of Lower Genital Tract Neoplasia Compared With Low-Risk Women.
    Robison K; Cronin B; Bregar A; Luis C; DiSilvestro P; Schechter S; Pisharodi L; Raker C; Clark M
    Obstet Gynecol; 2015 Dec; 126(6):1294-1300. PubMed ID: 26551180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.
    Frisch M; Biggar RJ; Goedert JJ
    J Natl Cancer Inst; 2000 Sep; 92(18):1500-10. PubMed ID: 10995805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.